Today's Top Stories

Highlights from press releases posted on 23 September 2020

23 Sep, 2020, 12:13 BSTJohnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen's COVID-19 Vaccine Candidate

First participants dosed in Phase 3 trial (ENSEMBLE) evaluating safety and efficacy of Janssen's COVID-19 vaccine candidate, JNJ-78436735, also known as Ad26.COV2.S NEW BRUNSWICK, New Jersey, Sept. 23, 2020 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) (the Company) today announced the launch of...


23 Sep, 2020, 11:38 BSTEuropean Datawarehouse Submits Application to ESMA to be Registered

FRANKFURT, Germany, Sept. 23, 2020 /PRNewswire/ -- European DataWarehouse (EDW)...


23 Sep, 2020, 10:00 BSTLCI And Sumitomo Mitsui Finance And Leasing (SMFL) Launch Landmark

LONDON, Sept. 23, 2020 /PRNewswire/ -- LCI, a leading helicopter lessor and the...


23 Sep, 2020, 08:40 BSTSHAREit Rides the Mobile Application Wave

JOHANNESBURG, Sept. 23, 2020 /PRNewswire/ -- Multi-utility applications like...


23 Sep, 2020, 04:12 BSTNewly launched Veilish fabric window film combining convenience and

SEOUL, South Korea, Sept. 23, 2020 /PRNewswire/ -- SIPOS, the manufacturer of...